Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Biogen Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

Microsoft Excel
Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Due from anti-CD20 therapeutic programs
Inventory
Assets held for sale
Other current assets
Current assets
Marketable securities
Property, plant and equipment, net
Operating lease assets
Intangible assets, net
Goodwill
Deferred tax asset
Investments and other assets
Long-term assets
Total assets

Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).


The data reveals several noteworthy trends in the quarterly financial metrics.

Liquidity and Cash Position
Cash and cash equivalents experienced significant variability, peaking notably in early 2018 and fluctuating through late 2022, with the highest values observed at the end of 2022. Marketable securities displayed a decreasing pattern in the early periods of 2017-2018 but showed some recovery towards late 2019 and into 2022. The combination of cash and marketable securities indicates fluctuating but generally substantial liquid resources.
Receivables and Working Capital Assets
Accounts receivable showed a relatively steady range through the periods but generally declined slightly after 2019, suggesting moderately stable but possibly tighter credit management or lower sales volume. The amounts due from anti-CD20 therapeutic programs fluctuated with some declines after 2019, which may reflect changes in program delivery or billing cycles. Inventory levels increased over the years, especially after 2019, indicating accumulation or stockpiling possibly in anticipation of demand or production changes.
Other Current Assets and Assets Held for Sale
Other current assets initially declined from 2017 through 2018, then exhibited an increasing trend after 2021, including a large spike mid-2022, which could point to changes in prepaid expenses or other receivables. Assets held for sale appeared as a notable item only around 2019, implying some disposal or restructuring activity during that period.
Property, Plant, Equipment, and Intangible Assets
Property, plant, and equipment increased steadily until the end of 2018, reflecting ongoing capital investment, but showed slight decreases post-2019. Intangible assets consistently declined from 2017 through 2022, which may indicate amortization or asset impairments. Goodwill steadily increased until 2018 and remained fairly stable afterwards, suggesting no significant impairments or acquisitions affecting goodwill during recent periods.
Deferred Tax Assets and Long-Term Assets
Deferred tax assets rose sharply during 2017-2018 and peaked around 2019, followed by a steady decline through 2022, indicating utilization or revaluation of tax benefits. Long-term assets increased gradually until around 2019 before trending downward towards 2022, reflecting changes in capital investments and asset revaluations.
Total Assets
Total assets followed an increasing trend through 2018, peaking in 2019, but gradually declined afterward through late 2022, which may suggest asset sales, depreciation, or strategic realignment of the asset base.

Overall, the data indicates a period of growth in asset size up through 2019, followed by a consolidation or reduction phase. Liquidity fluctuated significantly but remained ample. Capital expenditures appeared to slow post-2018, with a marked reduction in intangible assets and deferred tax assets after 2019. Inventory trends suggest preparation for higher future demand or operational changes. The appearance of assets held for sale in 2019 signals potential restructuring initiatives within that timeframe. These patterns collectively illustrate a company adapting its asset base and liquidity management in response to evolving operational and market conditions.


Assets: Selected Items


Current Assets: Selected Items